Interventional Cardiology Peripheral Vascular Devices Market: Market Size & Forecast 2026

The interventional cardiology and peripheral vascular devices market covers a broad array of minimally invasive medical instruments used to treat blockages and diseases affecting coronary and peripheral blood vessels. Key product categories include angioplasty balloons, stents, guidewires, catheters, atherectomy devices, drug-eluting technologies, and imaging systems such as IVUS and OCT. The market benefits from a global shift toward less invasive treatment alternatives compared to open surgical procedures.

• •2025 market size is estimated at approximately $7.6 billion, with long-term forecasts ranging from $10.8 billion to over $20 billion by the early 2030s depending on scope and methodology
• •Product portfolio spans stents, balloons, catheters, guidewires, atherectomy devices, vascular closure devices, and intravascular imaging tools
• •Market benefits from clinical preference for minimally invasive over open surgical interventions

A primary driver is the rising global incidence of peripheral artery disease and coronary artery disease, closely linked to increasing rates of diabetes, obesity, and sedentary lifestyles. An aging population worldwide means a larger patient demographic requiring interventional vascular treatments. Additionally, continued medical device innovation, including drug-eluting technologies, bioresorbable scaffolds, and advanced imaging, supports expanded adoption and higher per-procedure value.

• •Rising prevalence of peripheral artery disease driven by diabetes, hypertension, and sedentary lifestyles
• •Aging global population increasing the pool of patients requiring vascular interventions
• •Technological innovation in drug-eluting devices, bioresorbable scaffolds, and intravascular imaging driving procedural adoption

The market is segmented by product type, stents, balloons, catheters, guidewires, atherectomy devices, and others, as well as by end user, including hospitals, specialty clinics, and ambulatory surgery centers. Geographically, North America historically leads the market due to advanced healthcare infrastructure and high procedure volumes, while Europe and Asia-Pacific are the next largest regions. The Asia-Pacific region is expected to post the strongest growth, driven by improving healthcare access, rising disease burden, and expanding medical device manufacturing capacity.

• •North America holds the largest share, supported by advanced healthcare infrastructure and high interventional procedure rates
• •Asia-Pacific is the fastest-growing region, fueled by rising disease burden, improving healthcare access, and growing domestic manufacturing
• •Europe represents a mature market with steady demand supported by aging demographics and established reimbursement frameworks

What are the recent trends and outlook?

Key trends shaping the market include the growing adoption of drug-coated balloons and drug-eluting technologies to reduce restenosis rates, as well as increased utilization of chronic total occlusion and atherectomy devices for complex peripheral lesions. The shift toward outpatient and ambulatory settings is influencing product design and market access strategies. Over the forecast horizon, the market is expected to sustain solid growth, with the combined interventional cardiology and peripheral vascular devices market potentially reaching $15 billion to $20 billion or more by the early 2030s.

• •Drug-coated and drug-eluting technologies gaining adoption to improve long-term procedural outcomes and reduce restenosis
• •Growth in atherectomy and chronic total occlusion procedures supporting expansion of the complex intervention segment
• •Shift toward ambulatory and outpatient settings influencing product development and hospital procurement strategies